Flyp is a medical device, portable and easier to follow treatment plan for COPD, asthma, and other respiratory conditions.
Flyp Nebulizer has raised $25.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2021.
Flyp Nebulizer's investors include Connecticut Innovations, Stonehenge Capital, HighCape Partners, Benslie Investment Group.
Flyp Nebulizer is headquartered in Fairfield, United States.
Flyp is a medical device, portable and easier to follow treatment plan for COPD, asthma, and other respiratory conditions.
Flyp Nebulizer is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flyp Nebulizer — Funding & Investors." VCBacked, November 8, 2021, https://www.vcbacked.co/company/flyp-nebulizer. Accessed September 30, 2026.
VCBacked. (2021). Flyp Nebulizer — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/flyp-nebulizer
{{cite web |title=Flyp Nebulizer — Funding & Investors |url=https://www.vcbacked.co/company/flyp-nebulizer |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated